Terms ending in 2039
Every in-force patent on Vanrx Pharmasystems Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,370,565 | Peristaltic Pump-Based Apparatus and Method for the Controlled Dispensing of Fluids In force · High confidence | Vanrx Pharmasystems Inc. | In force | High confidence | |
| US 12,139,284 | Peristaltic Pump-Based Apparatus and Method for the Controlled Dispensing of Fluids In force · High confidence | Vanrx Pharmasystems Inc. | In force | High confidence | |
| US 11,014,697 | Peristaltic Pump-Based Apparatus and Method for the Controlled Dispensing of Fluids In force · High confidence | Vanrx Pharmasystems Inc. | In force | High confidence | |
| US 11,230,400 | Method, Device and System for Filling Pharmaceutical Containers In force · High confidence | Vanrx Pharmasystems Inc. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.